12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Galenica, Zeria deal

Galenica's Vifor Pharma Ltd. specialty pharma business granted Zeria exclusive, Japanese rights to develop and commercialize Ferinject ferric carboxymaltose to treat iron deficiency anemia. The non-dextran IV iron replacement is...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >